Clinical trials recruiting for Chronic Kidney Disease Stage 5
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Dapagliflozin 10 mg | 1 |
| Peptide vaccine | 1 |
| QS21 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 1 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
- An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients
- BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
- CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
- Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
Related conditions
Trials recruiting for Chronic Kidney Disease Stage 5 often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic Kidney Disease Stage 5 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.